[1]
|
Adair, R. F., & Holmgren, L. R. (2005). Do drug samples influence resident prescribing behavior? A randomized trial. The American Journal of Medicine, 118, 881-884.
doi:10.1016/j.amjmed.2005.02.031
|
[2]
|
Association of American Medical Colleges (AAMC) (2008). Industry funding of medical education: report of an AAMC task force. URL (last checked 2 March 2013).
https://members.aamc.org/eweb/upload/Industry%20Funding%20of%20Medical%20Education.pdf
|
[3]
|
American Medical Student Association (AMSA) (2012). AMSA PharmFree scorecard 2011-2012. URL (last checked 2 March 2013).
http://www.amsascorecard.org
|
[4]
|
Bekelman, J. E., Li, Y., & Gross, C. P. (2003). Scope and impact of financial conflicts of interest in biomedical research: A systematic review. Journal of the American Medical Association, 289, 454-465. doi:10.1001/jama.289.4.454
|
[5]
|
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., Goldman, J., Kassirer, J. P., Kimball, H., Naughton, J., & Smelser, N. (2006). Health industry practices that create conflicts of interest. A policy proposal for academic medical centers. Journal of the American Medical Association, 295, 429-433.
doi:10.1001/jama.295.4.429
|
[6]
|
Canadian Foundation of Medical Students (CFMS) (2011). Defining the relationship: An evidence based review and recommendations on the role of industry funding in medical schools. URL (last checked 2 March 2013).
http://www.cfms.org/attachments/article/163/cfms_industry_funding_working_group_paper.pdf
|
[7]
|
Canadian Medical Association (CMA) (2007). Guidelines for physiccians in interactions with industry: CMA Policy. URL (last checked 2 March 2013).
http://policybase.cma.ca/dbtw-wpd/Policypdf/PD08-01.pdf
|
[8]
|
Chimonas, S., Patterson, L., Raveis, V. H., & Rothman, D. J. (2011). Managing conflicts of interest in clinical care: A national survey of policies at US medical schools. Academic Medicine, 86, 293-299. doi:10.1097/ACM.0b013e3182087156
|
[9]
|
Choudhry, N. K., Stelfox, H. T., & Detsky, A. S. (2002). Relationships between authors of clinical practice guidelines and the pharmaceutical industry. Journal of the American Medical Association, 287, 612- 617. doi:10.1001/jama.287.5.612
|
[10]
|
Dana, J., & Loewenstein, G. (2003) A social science perspective on gifts to physicians from industry. Journal of the American Medical Association, 290, 252-255. doi:10.1001/jama.290.2.252
|
[11]
|
Gangon, M. A., & Lexchin, J. (2008). The cost of pushing pills: A new estimate of pharmaceutical promotion expenditure in the United States. PLOS Medicine, 5, 29-33.
|
[12]
|
Institutes of Medicine (IOM) (2009). Conflict of interest in medical research, education, and practice. URL (last checked 2 March 2013).
http://www.nap.edu/catalog.php?record_id=12598
|
[13]
|
Lexchin, J., Bero, L. A., Djubegovic, B., & Clark, O. (2003). Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ, 326, 1167-1170.
doi:10.1136/bmj.326.7400.1167
|
[14]
|
Lexchin, J., Sekeres, M., Gold, J., Ferris, L.E., Kalkar, S. R., Wu, W., Van Laethem, M., Chan, A. W., Mohen, D., Maskalyk, M. J., Taback, N., & Rochon, P. A. (2008). National evaluation of policies on individual financial conflicts of interest in Canadian academic health science centers. Journal of General Internal Medicine, 23, 1896-1903.
doi:10.1007/s11606-008-0752-4
|
[15]
|
Mathieu, G., Smith, E., Potvin, M. J., & Williams-Jones, B. (2012). Conflict of interest policies at Canadian universities and medical schools: Some lessons learned from the AMSA PharmFree Scorecard. Bioethique Online, 1, 1-11.
|
[16]
|
McCormick, B. B., Tomlinson, G., Brill-Edwards, P., & Detsky, A. S. (2001). Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on post training attitudes and behavior. Journal of the American Medical Association, 286, 1994-1999. doi:10.1001/jama.286.16.1994
|
[17]
|
Morgan, M. A., Dana, J., Loewenstein, G., Zinberg, S., & Schulkin, J. (2006). Interactions of doctors with the pharmaceutical industry. Journal of Medical Ethics, 32, 559-563.
doi:10.1136/jme.2005.014480
|
[18]
|
Neuman, J., Korenstein, D., Ross, J. S., & Keyhani, S. (2011). Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: Cross sectional study. BMJ, 343, d5621. doi:10.1136/bmj.d5621
|
[19]
|
Okike, K., Kocher, M. S., Wei, E. X., Mehlman, C. T., & Bhandari, M. (2009). Accuracy of conflict-of-interest disclosures reported by physicians. The New England Journal of Medicine, 361, 1466-1474.
doi:10.1056/NEJMsa0807160
|
[20]
|
Rochon, P. A., Sekeres, M., Hoey, J., Lexchin, J., Ferris, L. E., Moher, D., Wu, W., Kalkar, S. R., Van Laethem, M., Gruneir, A., Gold, J., Maskalyk, J., Streiner, D. L., Taback, N., & Chan, A. W. (2011). Investigator experiences with financial conflicts of interest in clinical trials. Trials, 12, 1-9. doi:10.1186/1745-6215-12-9
|
[21]
|
Smith, E., & Williams-Jones, B (2009). Legalistic or inspirational? Comparing university conflict of interest policies. Higher Education Policy, 22, 433-459. doi:10.1057/hep.2009.3
|
[22]
|
Standing Committee on Continuing Professional Development (SCCPD) (2010). SCCPD position paper on the role of industry in university-based CME/CPD Offices and Industry Relations. URL (last checked 2 March 2013).
http://www.afmc.ca/pdf/committees/SCCPD_Position_Paper_on_Role_of_Industry_in_ University_Based_CME-CPD_Dec%201_2010.pdf
|
[23]
|
Thompson, D. (1993). Understanding financial conflicts of interest. New England Journal of Medicine, 329, 573-576.
doi:10.1056/NEJM199308193290812
|
[24]
|
Wazana, A. (2000). Physicians and the pharmaceutical industry. Is a gift every just a gift? Journal of the American Medical Association, 283, 373-380. doi:10.1001/jama.283.3.373
|
[25]
|
Williams-Jones, B., & MacDonald, C. (2008). Conflict of interest policies at Canadian universities: clarity and content. Journal of Academic Ethics, 6, 79-90. doi:10.1007/s10805-007-9052-6
|
[26]
|
Zipkin, D. A., & Steinman, M. A. (2005). Interactions between pharmaceutical representatives and doctors in training: A thematic review. Journal of General Internal Medicine, 20, 777-786.
doi:10.1111/j.1525-1497.2005.0134.x
|